Atypical posterior reversible encephalopathy syndrome associated with Lenvatinib therapy in a patient with metastatic thyroid cancer—A case report

Posterior reversible encephalopathy syndrome (PRES) is a disorder of reversible subcortical vasogenic brain oedema in patients with acute neurological symptoms. Drug‐induced PRES has been described with the usage of drugs that target receptors regulating vascular permeability or altering immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Abhishek, Mahajan, Renuka, Ashtekar, Ujjwal, Agarwal, Amit, Choudhari, Vijay, Patil, Vanita, Noronha, Nandini, Menon, Kumar, Prabash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458498/
https://www.ncbi.nlm.nih.gov/pubmed/35243821
http://dx.doi.org/10.1002/cnr2.1605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458498/
https://www.ncbi.nlm.nih.gov/pubmed/35243821
http://dx.doi.org/10.1002/cnr2.1605

Ejemplares similares